2-HYdrazinyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Catalog No.: 
ACTWPZ483
CAS No.: 
1353716-54-7
Molecular Formula: 
C11H18BN3O2
Molecular Weight: 
235.10
2-HYdrazinyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$180.00InquiryInquiry
1g95%$545.00InquiryInquiry
5g95%$2698.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-HYdrazinyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
IUPAC Name2-hydrazineyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Molecular FormulaC11H18BN3O2
Molecular Weight235.10
SMILESCC1(OB(C2=CC=CN=C2NN)OC1(C)C)C
InChI KeyDFIHPRPZDLWIFL-UHFFFAOYSA-N
SynonymPyridine, 2-hydrazinyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;2-Hydrazinyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
CAS No.1353716-54-7

Synthetic Route by SureRoute

1. ACTWPZ483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPWGJ827 route compound structure diagram
    ACPWGJ827452972-11-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTWPZ483 route product structure diagram
    ACTWPZ4831353716-54-7
Inquiry

2. ACTWPZ483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFKUT582 route compound structure diagram
    ACFKUT582452972-14-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTWPZ483 route product structure diagram
    ACTWPZ4831353716-54-7
Inquiry

3. ACTWPZ483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. ACFJMO943 route compound structure diagram
    ACFJMO94354231-41-3In Stock
  4. Then
  5. ACTWPZ483 route product structure diagram
    ACTWPZ4831353716-54-7
Inquiry

Comments (0)